drugset / Trial / NCT03401593
Long Term Evaluation and Management of Atrial Fibrillation in Pacemaker Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is prospective randomized study which was performed in multicenter (General Hospital) in Korea. Inclusion criteria is patients who developed atrial fibrillation/flutter/tachycardia after pacemaker implantation among AF-pacemaker study (ClinicalTrials.gov Identifier: NCT03303872). The purpose is to investigate the recurrence rate of AF/AFL/AT in both groups after randomization for 60 months (5 years) in patients post pacemaker implantation and assess long term clinical results.
Timeline
- Start
- 2019-10
- Primary completion
- 2028-06
- Completion
- 2028-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fentanyl | Other / unclassified | — | — |
| Comparator | Midazolam | Small molecule | — | — |
Indications
No indication recorded.